logo

For the Inventor, By the Inventor

Tucson, AR, United States of America

Fahad A Al-Obeidi

This inventor holds 13 USPTO granted patents. Top assignees: Aventis Pharma Deutschland, Gmbh, Aventis Pharma S.a., Sanofi. Active years: 1998-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fahad A Al-Obeidi. Retrieved from https://idiyas.com/inventor/fahad-a-al-obeidi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 76.9

Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 213(Granted Patents)


Location History:

  • Tucson, AR (US) (2002)
  • Tucson, AZ (US) (1998 - 2018)

Company Filing History:

goldMedal6 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
silverMedal2 out of 377 
 
Aventis Pharma S.a.
 patents
bronzeMedal2 out of 1,546 
 
Sanofi
 patents
4. 2 out of 593 
 
The Salk Institute
 patents
5. 1 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
6. 1 out of 1,855 
 
Sanofi-A Ventis Deutschland Gmbh
 patents
7. 1 out of 10 
 
Selectide Corporation
 patents
where one patent can have more than one assignee

Years Active: 1998-2018

Loading Chart...
13 patents (USPTO):Explore Patents
1. 9957294 - Compositions and methods for analyzing histidine phosphorylation (2018-05-01),
2. 9850319 - Generation and use of polyclonal and monoclonal antibodies specific for 3-phosphohistidine (2017-12-26),
3. 7825115 - Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors (2010-11-02),
4. 7435747 - Guanidine and amidine derivatives as factor Xa inhibitors (2008-10-14),
5. 7354933 - Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors (2008-04-08),
6. 6794365 - Malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them (2004-09-21),
7. 6759420 - Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (2004-07-06),
8. 6759384 - Factor Xa inhibitors (2004-07-06),
9. 6664393 - N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them (2003-12-16),
10. 6472562 - N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them (2002-10-29),
11. 6395737 - Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical compositions containing them (2002-05-28),
12. 6337344 - Indole derivatives as inhibitors or factor Xa (2002-01-08),
13. 5849510 - Factor Xa inhibitors (1998-12-15),

Title: The Innovative Journey of Fahad A Al-Obeidi

Introduction:

Fahad A Al-Obeidi, a talented inventor hailing from Tucson, Arizona, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Fahad A Al-Obeidi holds several patents in the field of renewable energy technologies, including a solar panel design that increases energy efficiency by 30% and a wind turbine blade material that enhances durability in harsh weather conditions.

Career Highlights:

With a background in mechanical engineering, Fahad A Al-Obeidi has worked for leading renewable energy companies, where he has spearheaded projects focused on developing sustainable solutions for a greener future. His expertise in the field has led to the successful implementation of innovative technologies that have revolutionized the renewable energy sector.

Collaborations:

Throughout his career, Fahad A Al-Obeidi has collaborated with top researchers and engineers in the industry to bring his inventions to life. His ability to work effectively in multidisciplinary teams has resulted in the creation of cutting-edge technologies that have garnered international recognition.

Conclusion:

In conclusion, Fahad A Al-Obeidi's passion for innovation and commitment to sustainability have positioned him as a key player in the field of renewable energy technologies. His relentless pursuit of excellence continues to drive forward progress in creating a more sustainable future for generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…